Skip to main content

Ovarian Hyperstimulation Syndrome

Question for Department of Health

UIN HL2640, tabled on 4 November 2014

To ask Her Majesty’s Government, further to the Written Answer by the Parliamentary Under-Secretary of State for Public Health, Jane Ellison, on 12 September (HC Deb, col 750W), what evidence would be required to predict the cohort of patients that may develop ovarian hyperstimulation syndrome; whether the incidence of ovarian hyperstimulation syndrome would be part of any such evidence base; and, if not, why not.

Answered on

18 November 2014

The Human Fertilisation and Embryology Authority (HFEA) has advised that, with regard to the Human Fertility journal article, it has nothing to add to the answers given to the noble Lord on 22 October 2008 (Official Report WA110), 9 July 2012 (Official Report, cols. WA 202-3) and 8 January 2013 (WA23). Data regarding the cohort of patients described in Fertility and Sterility (volume 101, issue 4, pages 967–973) were not shared with the HFEA. However, the HFEA has access to the published article.

It would be for clinicians and professional bodies to decide on the evidence required to predict the cohort of patients that may develop ovarian hyperstimulation syndrome and to treat symptoms in accordance with guidelines.

As outlined in the answer given on 23 Jan 2013 (Official Report WA217), the HFEA would refer to evidence based guidelines, produced by the National Institute for Health and Care Excellence, on these matters.